EFFECTS OF THE CHOLECYSTOKININ RECEPTOR ANTAGONIST L-364,718 ON PANCREATITIS INDUCED BY A DEFICIENT IN CHOLINE AND SUPPLEMENTED WITH ETHIONINE (CDE) DIET IN THE RAT
Ma. Manso et al., EFFECTS OF THE CHOLECYSTOKININ RECEPTOR ANTAGONIST L-364,718 ON PANCREATITIS INDUCED BY A DEFICIENT IN CHOLINE AND SUPPLEMENTED WITH ETHIONINE (CDE) DIET IN THE RAT, Archives of physiology and biochemistry, 103(4), 1995, pp. 410-415
The role of cholecystokinin (CCK) in the development of a necrotizing
acute pancreatitis induced by a diet deficient in choline and suppleme
nted with ethionine (CDE) has been evaluated in the rat by using a pot
ent CCK receptor antagonist L364,718. Acute pancreatitis was induced b
y administration of CDE diet for 14 days. L-364,718 administration was
carried out by subcutaneous injections at dose of 0.1 mg/kg/day. panc
reatic exocrine secretion (flow, protein, amylase and trypsin outputs)
in resting and under infusion of 1.25 mu g/kg/h of CCK-8 were used to
evaluate the pancreatic functionality. Others parameters (serum amyla
se, percentage fluid in pancreas, haematocrit and mortality) evaluated
the severity of pancreatitis. L-364, 718 slightly reduced the mortali
ty and the increases of percentage of fluid accumulated in pancreas in
CDE diet acute pancreatitis. Basal and CCK stimulated pancreatic secr
etion was significantly depressed 36 hours after L-364,718 treatment A
slight response to CCK was observed. Nevertheless it was lower than u
sually observed in control rats. Our results demonstrate that in the r
at chronic L-364,718 treatment did not completely restore pancreatic a
ctivity in acute pancreatitis induced by CDE diet Hence CCK cannot be
considered as the main factor involved in the development of this panc
reatitis model.